Litcius/Paper detail

Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition

Fateen Ata, Hiba Magboul, Haneen Toba, Hadeel Alfar, Adel Al Bozom, Khaled Murshed, Muhammad Zahid

2022Clinical Case Reports14 citationsDOIOpen Access PDF

Abstract

Rifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin-induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.

Topics & Concepts

MedicineHemolysisRifampicinNephrotoxicityAcute kidney injuryTuberculosisAcute tubular necrosisDrugIntensive care medicineKidneyPharmacologyInternal medicinePathologyNephrotoxicity and Medicinal PlantsDrug-Induced Hepatotoxicity and ProtectionDrug-Induced Adverse Reactions
Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition | Litcius